
PureTech Health gets US$11.4m to advance LYT-300
PureTech Health plc has been awarded up to $11.4 million from the US government to advance LYT-300 (oral allopregnanolone) for the treatment of...

BioSenic halts ALLOB development
ALLOB was developed before the US$40.8m majority buyout of Bone Therapeutics by French Medsenic SAS last October. Before the reverse merger, in...

French Carthera closes €37.5m Series B financing round
A prominent (undisclosed) investor led the round alongside the European Innovation Council Fund (EICF) and existing investors including Panakès...

Radiotherapy R&D partnership
French-US company Orano Med is developing Lead-212 (212Pb) Targeted Alpha Therapy, which combines the ability of biological molecules such as...

Dutch go first: pre-approval tastings of cultivated meat & seafood in the Netherlands
Mosa Meat and Meatable welcome the agreement with the Dutch government to conduct pre-approval tastings of cultured meat and seafood in the...

Lilly presents impressing results for Alzheimer's drug donanemab
Donanemab is the second antibody, after Eisai’s/Biogen’s accelarated approved lecanemab, that can slow the progression of dementia in early-stage...

Neogap fully takes over TCER Oncology shares
Neogap Therapeutics A/B was joined by new shareholders Prof. Rolf Kiessling and his team member Stina Wickström who took over the remaining...